Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Names Alacris CSP for Target Enrichment

NEW YORK (GenomeWeb) – Agilent Technologies today said it named Alacris Theranostics an Agilent Certified Service Provider for target enrichment. 

Alacris is based in Berlin and provides molecular analysis and bioinformatics through an approach called ModCell, which is intended to match patients with appropriate therapies. According to Agilent, Alacris exploits next-generation sequencing and other omics data to facilitate drug development and personalized medicine in cancer and other complex diseases. 

ModCell was developed at the Max Planck Institute for Molecular Genetics and is exclusively licensed to Alacris. 

For its CSP program, Agilent chooses companies that will leverage Agilent's technologies in providing analysis services. Agilent trains the firms on its workflow to ensure that customers receive consistent data quality, reproducibility, and reliability, it said. 

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.